| Literature DB >> 30155366 |
Elif Bozcal1, Vahap Eldem2, Sohret Aydemir3, Mikael Skurnik4.
Abstract
BACKGROUND: Extraintestinal pathogenic Escherichia coli (ExPEC) is an important bacterium and responsible for many bloodstream infections, including urinary tract infections and even fatal bacteremia. The aim of this research was to investigate whether ExPEC strains isolated from Turkish blood cultures have a relationship between 16S rRNA based phylogenetic clusters and antibiotic resistance profiles, virulence factors or clonal lineages.Entities:
Keywords: 16S rRNA; Escherichia coli; MLST; ST131; Virulence; antibiotic resistance
Year: 2018 PMID: 30155366 PMCID: PMC6110251 DOI: 10.7717/peerj.5470
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Distribution of hospital departments among ExPEC isolates.
The number of departments where ExPEC isolates (n = 97) originated was shown on the pie chart. Newborn-ICU, Newborn- Intensive Care Unit
Primers used in this study.
| Gene | Sequence (5′ → 3′) | Size (bp) | Description | Reference |
|---|---|---|---|---|
| GAC GAA CCA ACG GTC AGG AT | 279 | Hemetransport in Enterohemorrhagic O157:H7 | ||
| TGC CGC CAG TAC CAA AGA CA | ||||
| TGA AGT GTC AGG AGA CGC TG | 211 | Protein of function unknown | ||
| ATG GAG AAT GCG TTC CTC AAC | ||||
| GAG TAA TGT CGG GGC ATT CA | 152 | Putative DNA fragment (TSPE4.C2) in | ||
| CGC GCC AAC AAA GTA TTA CG | ||||
| AAC AAG GAT AAG CAC TGT TCT GGC | 1,777 | Hemolysin | ||
| ACC ATA TAA GCG GTC ATT CCC GTC | ||||
| AAGATGGAG TTT CCT ATGCAGGAG | 498 | Cytotoxic necrotizing factor 1 | ||
| CAT TCA GAG TCC TGC CCT CAT TAT T | ||||
| GGC TGG ACA TCA TGG GAA CTG G | 302 | Aerobactin siderophore receptor | ||
| CGT CGG GAA CGG GTA GAA TCG | ||||
| TGA TTA ACC CCG CGA CGG AA | 880 | Yersiniabactin | ||
| CGC AGT AGG CAC GAT CTT GTA | ||||
| AAT CCG GCA AAG AGA CGA ACC GCC T | 553 | Salmochelin siderophore receptor | ||
| GTT CGG GCA ACC CCT GCT TTG ACT TT | ||||
| CTG TAA TTA CGG AAG TGA TTT CTG | 1,070 | P fimbriae | ||
| ACT ATC CGG CTC CGG ATA AAC CAT | ||||
| GTG GAT ACG ACG ATT ACT GTG | 240 | Sfa fimbriae | ||
| CCG CCA GCA TTC CCT GTA TTC | ||||
| CAG CAA CCC GAA CCA CTT GAT G | 323 | Episomal increased serum survival | ||
| AGC ATT GCC AGA GCG GCA GAA | ||||
| GGT GTG GTG CGA TGA GCA CAG | 290 | Serum resistance | ||
| CAC GGT TCA GCC ATC CCT GAG | ||||
| AGG CAG GTG TGC GCC GCG TAC | 170 | Invasion of brain endothelium | ||
| TGG TGC TCC GGC AAA CCA TGC | ||||
| GCGCAT TTGCTGATA CTGTTG | 272 | Capsule synthesis K1 e K5 | ||
| CAT CCA GAC GAT AAG CAT GAG CA | ||||
| TCA TCC CGG AAG CCT CCC TCA CTA CTA T | 496 | Episomal outer membrane protease | ||
| TAG CGT TTG CTG CAC TGG CTT CTG ATA C | ||||
| TACCGACGACGCCGATCTG | 300 | O-typing O25b serotype | ||
| TGCTATTCATTATGCGCAGC | ||||
| GGACATCCTGTTACAGCGCGCA | 930 | pathogenicity-associated island (PAI) marker | ||
| TCGCCACCAATCACAGCCGAAC | ||||
| ATTCTGCTTGGCGCTCCGGG | 583 | adenylate kinase | ||
| CCGTCAACTTTCGCGTATTT | ||||
| TCACAGGTCGCCAGCGCTTC | 806 | fumarate hydratase | ||
| GTACGCAGCGAAAAAGATTC | ||||
| TCGGCGACACGGATGACGGC | 911 | DNA gyrase | ||
| ATCAGGCCTTCACGCGCATC | ||||
| ATGGAAAGTAAAGTAGTTGTT CCGGCACA | 878 | isocitrate/isopropylmalate dehydrogenase | ||
| GGACGCAGCAGGATCTGTT | ||||
| ATGAAAGTCGCAGTCCTCGGCGCT GCTGGCGG | 932 | malate dehydrogenase | ||
| TTAACGAACTCCTGCCCCAGAGCG ATATCTTTCTT | ||||
| CGCGCTGATGAAAGAGATGA | 816 | adenylosuccinate dehydrogenase | ||
| CATACGGTAAGCCACGCAGA | ||||
| CGCATTCGCTTTACCCTGACC | 780 | ATP/GTP binding motif | ||
| AGCGTGAAGGTAAAACCTGTG | ||||
| AGAGTTTGATCCTGGCTCAG | 1,465 | 16S rRNA, partial gene | ||
| GGTTACCTTGTTACGACTT |
Extra intestinal pathogenic Escherichia coli (ExPEC) reference strains.
| ID_NCBI | Strain | Description | Reference |
|---|---|---|---|
| Highly Virulent CTX-M-15-Producing H30-Rx Subclone of | |||
| Multidrug-Resistant Uropathogenic | |||
| Uropathogenic | |||
| Commensal strain-isolated in the 2000s from the faeces of a healthy man in France | |||
| UTI89 is a uropathogenic | |||
| Avian pathogenic | |||
| Isolated in 1999 from the cerebro-spinal fluid of a new born with late-onset neonatal meningitis in France | |||
| Extraintestinal pathogenic | |||
| A commensal bacterium was isolated from the feces of a healthy human adult. It belongs to the | |||
| Isolated from the faeces at 1980s in France | |||
| Strain DH10B is a derivative of the already sequenced K12 | |||
Antibiotic susceptibility profiles of the ExPEC isolates.
| Antibiotic | Antibiotic susceptibility | |||||
|---|---|---|---|---|---|---|
| R | I | S | ||||
| % | % | % | ||||
| Ampicillin | 72 | 74.22 | n.a. | n.a. | 21 | 21.64 |
| Amoxicillin clavulanic acid | 38 | 39.17 | n.a. | n.a. | n.a. | n.a. |
| Cefuroxime axetil | 64 | 65.97 | n.a. | n.a. | 7 | 7.21 |
| Ceftriaxone | 56 | 57.73 | n.a. | n.a. | n.a. | n.a. |
| Trimethoprim-sulfamethoxazole | 55 | 56.70 | n.a. | n.a. | 20 | 41.7 |
| Cefepime | 47 | 48.45 | 6 | 6.18 | n.a. | n.a. |
| Gentamicin | 31 | 31.95 | 1 | 1.03 | 21 | 20.61 |
| Piperacillin/tazobactam | 29 | 29.89 | 16 | 16.49 | n.a. | n.a. |
| Ciprofloxacin | 31 | 31.95 | 1 | 1.03 | 8 | 8.24 |
| Amikacin | n.a. | n.a. | 18 | 18.55 | 2 | 2.06 |
| Ertapenem | 2 | 2.06 | n.a. | n.a. | n.a. | n.a. |
| Ceftazidime | 2 | 2.06 | n.a. | n.a. | n.a. | n.a. |
| Cefuroxime | 28 | 28.86 | 1 | 1.03 | n.a. | n.a. |
Notes.
not applicable
resistant
intermediate resistant
susceptible
number of ExPEC isolates
Figure 2Distribution of virulence genes among ExPEC isolates.
The bar plot was constructed for 97 ExPEC isolates to illustrate virulence genes distribution. The numbers presented at the top of bars demonstrated the number of virulence genes. PAI: pathogenicity-associated island (PAI) marker (n = 40), ibeA, Invasion of brain endothelium (n = 2); hlyA, hemolysin (n = 15); cnf1, cytotoxic necrotizing factor (n = 7); iutA, Aerobactin siderophore receptor (n = 44); fyuA, Yersiniabactin (n = 49); iroN, Samochelin siderophore receptor (n = 23); papG, P fimbriae (n = 12); sfaS, Sfa fimbriae (n = 2); iss, Episomal increased serum survival; traT, serum resistance (n = 54), (n = 9); kpsII, Capsule synthesis K1 and K5 (n = 13); ompT, Episomal outer membrane protease (n = 13).
Figure 3Phylogenetic tree of ExPEC blood culture isolates based on 16S rRNA analysis.
The evolutionary history was inferred by using the Maximum Likelihood method based on the Hasegawa–Kishino–Yano model (Hasegawa, Kishino & Yano, 1985). The bootstrap consensus tree inferred from 1,000 replicates (Felsenstein, 1985) is taken to represent the evolutionary history of the taxa analyzed (Felsenstein, 1985). Branches corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. Initial tree(s) for the heuristic search were obtained by applying the Neighbor-Joining method to a matrix of pairwise distances estimated using the Maximum Composite Likelihood (MCL) approach. The analysis involved 111 nucleotide sequences (97 ExPEC isolate sequences and of the 14 related ExPEC strain sequences fetched from the NCBI GenBank database). All positions containing gaps and missing data were eliminated. There were a total of 382 positions in the final dataset. Evolutionary analyses were conducted in MEGA7 (Kumar, Stecher & Tamura, 2016). The symbols shown in the tree indicative for the sub-clusters that were closely related (blue filled circle, green filled circle, and red filled triangle)-(empty blue square and filled yellow square)-(empty lilac circle and aqua filled circle)-(purple filled triangle and lilac filled rhomb)-(empty black triangle)-(empty red circle)-(black filled square)-(red filled square)-(grey filled triangle)-(lime filled triangle)-(dark green filled circle)-(orange filled triangle)-(empty black rhomb)-(black filled circle)-(yellow filled triangle)-(empty orange square)-(empty black square)-(blue filled rhomb)-(empty black circle).
Sequence Type classification and allelic profiles of the phylogroup B2 of the ExPEC isolates.
| Isolate ID | ST | clonal complex | Phylogenetic classification | ESBL (+/-) | O25 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 131 | 53 | 40 | 47 | 13 | 36 | 28 | 29 | ST131 Cplx | B2 | + | + |
| 4 | 131 | 53 | 40 | 47 | 13 | 36 | 28 | 29 | ST131 Cplx | B2 | + | + |
| 5 | 95 | 37 | 38 | 19 | 37 | 17 | 11 | 26 | ST95 Cplx | B2 | − | |
| 6 | 131 | 53 | 40 | 47 | 13 | 36 | 28 | 29 | ST131 Cplx | B2 | + | + |
| 8 | 80 | 13 | 24 | 19 | 14 | 23 | 1 | 10 | ST568 Cplx | B2 | − | |
| 16 | 131 | 53 | 40 | 47 | 13 | 36 | 28 | 29 | ST131 Cplx | B2 | + | + |
| 17 | 14 | 14 | 14 | 10 | 14 | 17 | 7 | 10 | ST14 Cplx | B2 | − | |
| 19 | 10 | 550 | 11 | 4 | 8 | 8 | 8 | 2 | ST10 Cplx | B2 | + | |
| 22 | 69 | 21 | 35 | 27 | 6 | 5 | 5 | 4 | ST69 Cplx | B2 | − | |
| 24 | 131 | 53 | 40 | 47 | 13 | 36 | 472 | 29 | ST131 Cplx | B2 | + | |
| 28 | 131 | 53 | 40 | 47 | 13 | 36 | 28 | 29 | ST131 Cplx | B2 | + | + |
| 39 | 131 | 53 | 40 | 47 | 13 | 36 | 28 | 29 | ST131 Cplx | B2 | + | |
| 53 | 1722 | 101 | 4 | 97 | 29 | 70 | 158 | 2 | None | B2 | − | |
| 88 | 141 | 13 | 52 | 10 | 14 | 17 | 25 | 17 | None | B2 | − | |
| 95 | 131 | 53 | 40 | 47 | 13 | 36 | 28 | 29 | ST131 Cplx | B2 | + | |
| 96 | 1722 | 101 | 4 | 97 | 29 | 70 | 158 | 2 | None | B2 | − | |
| 99 | 88 | 518 | 4 | 12 | 1 | 20 | 12 | 7 | ST23 Cplx | B2 | + | |
| 100 | 131 | 53 | 40 | 25 | 13 | 36 | 28 | 29 | ST131 Cplx | B2 | + | |
| 101 | 998 | 13 | 52 | 156 | 14 | 17 | 25 | 17 | None | B2 | + | |
| 103 | 131 | 53 | 40 | 47 | 13 | 36 | 28 | 29 | ST131 Cplx | B2 | + | + |
Notes.
Extended-Spectrum β-lactamase
O25 serotype of ExPEC
sequence type